India Diabetes Diagnosis and Treatment Market to Reach $26.1 Billion by 2035

The Indian Diabetes Diagnosis and Treatment market was valued at $11.9 billion in 2025 and is expected to reach $26.1 billion by 2035, registering a CAGR of 8.2% during the forecast period from 2026 to 2035. The Indian Diabetes Diagnosis and Treatment Market is expanding steadily due to the sharp increase in diabetes prevalence across the country, which is directly intensifying demand for both diagnostic and therapeutic solutions. A growing patient pool is creating a sustained need for blood glucose monitoring (BGM), continuous glucose monitoring (CGM), insulin therapies, and oral anti-diabetic drugs. The shift toward earlier diagnosis and continuous disease management is further strengthening demand across both diagnosis and therapeutics segments. This trend is particularly significant in urban and semi-urban regions where lifestyle-related risk factors are more pronounced. As a result, the market is witnessing consistent expansion driven by long-term treatment dependency and recurring diagnostic usage.

Browse the full report description of “India Diabetes Diagnosis and Treatment Market Size, Share & Trends Analysis Report by Disease Type (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, and Prediabetes), by Diagnosis (Blood Glucose Monitoring (BGM), and Continuous Glucose Monitoring (CGM)), and by Therapeutics (Insulin, Oral Anti-diabetic Drugs, Non-Insulin Injectable Drugs, and Combination Drugs), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/indian-diabetes-diagnosis-and-treatment-market

Recent data strongly support this trend. According to the Indian Council of Medical Research–India Diabetes (ICMR-INDIAB) study published in 2023–2024, India has over 101 million people living with diabetes and 136 million individuals classified as prediabetic, indicating a massive at-risk population. Additionally, the International Diabetes Federation (IDF) Diabetes Atlas 2024 update estimates that India continues to have one of the largest diabetes populations globally, with projections showing continued growth through 2045. The Ministry of Health and Family Welfare also highlights increasing screening coverage under national programs, further expanding the diagnosed population. These figures confirm a strong and sustained demand base for both monitoring devices and therapeutic interventions in India.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • Disease Type
  • Diagnosis
  • Therapeutics
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape – Abbott India Limited, Becton Dickinson India Private Limited, Medtronic Private Limited, Novo Nordisk India Private Limited, Sanofi India Limited, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

India Diabetes Diagnosis and Treatment Market Report Segment

By Disease Type

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes
• Prediabetes

By Diagnosis

• Blood Glucose Monitoring (BGM)
• Continuous Glucose Monitoring (CGM)

By Therapeutics

• Insulin
• Oral Anti-Diabetic Drugs
• Non-Insulin Injectable Drugs
• Combination Drugs

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/indian-diabetes-diagnosis-and-treatment-market